home / stock / bmrn / bmrn news


BMRN News and Press, BioMarin Pharmaceutical Inc. From 06/07/24

Stock Information

Company Name: BioMarin Pharmaceutical Inc.
Stock Symbol: BMRN
Market: NASDAQ
Website: bmrn.com

Menu

BMRN BMRN Quote BMRN Short BMRN News BMRN Articles BMRN Message Board
Get BMRN Alerts

News, Short Squeeze, Breakout and More Instantly...

BMRN - BioMarin Presents New Phase 3, Four-Year Data Underscoring Long-Term Safety and Efficacy of ROCTAVIAN® (valoctocogene roxaparvovec-rvox) at International Society on Thrombosis and Haemostasis 2024 Congress

BioMarin Presents New Phase 3, Four-Year Data Underscoring Long-Term Safety and Efficacy of ROCTAVIAN® (valoctocogene roxaparvovec-rvox) at International Society on Thrombosis and Haemostasis 2024 Congress PR Newswire Data from Longest and Largest Hemophilia Gene Therapy ...

BMRN - Tracking Dan Loeb's Third Point Portfolio - Q1 2024 Update

2024-06-05 22:43:17 ET Summary Dan Loeb's 13F portfolio value increased from $6.64B to $7.85B in Q1 2024. The top three holdings account for approximately 34% of the entire portfolio. New stakes include Alphabet Inc., Advanced Auto Parts, Cinemark Holdings, Goldman Sachs, Marv...

BMRN - BMRN Price Target Alert: $91.00. Issued by Tudor Pickering

2024-06-04 16:00:04 ET William Pickering from Tudor Pickering issued a price target of $91.00 for BMRN on 2024-06-04 14:03:00. The adjusted price target was set to $91.00. At the time of the announcement, BMRN was trading at $78.87. The overall price target consensus is ...

BMRN - Market Perform Recommendation Issued On BMRN By Bernstein

2024-06-04 15:30:03 ET Bernstein analyst issues MARKET PERFORM recommendation for BMRN on June 4, 2024 02:03PM ET. The previous analyst recommendation was Market Perform. BMRN was trading at $78.865 at issue of the analyst recommendation. The overall analyst consensus : ...

BMRN - Overweight Recommendation Issued On BMRN By Wells Fargo

2024-06-04 15:30:03 ET Wells Fargo analyst issues OVERWEIGHT recommendation for BMRN on June 4, 2024 02:01PM ET. The previous analyst recommendation was Overweight. BMRN was trading at $78.865 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...

BMRN - Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2024 Update

2024-05-29 20:54:18 ET Summary Ole Andreas Halvorsen's 13F stock portfolio value decreased from $27.3B to $26.9B in Q1 2024. The number of holdings in the portfolio increased from 79 to 83. The largest five individual stock positions are Visa, Workday, Amazon.com, Philip Morri...

BMRN - Parnassus  Mid Cap Growth Fund Q1 2024 Investment Commentary

2024-05-26 08:10:00 ET Summary Parnassus Investments is a fundamental, bottoms-up investment firm offering responsible investment funds to the public. Parnassus Investments integrates comprehensive ESG evaluations with fundamental financial analysis to select investments. The Fund...

BMRN - Parnassus Value Equity Fund Q1 2024 Investment Commentary

2024-05-26 05:30:00 ET Summary Parnassus Investments is a fundamental, bottoms-up investment firm offering responsible investment funds to the public. Parnassus Investments integrates comprehensive ESG evaluations with fundamental financial analysis to select investments. The Fund...

BMRN - US Companies Moving the Markets, Morning edition
Thu, May 23, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) rose 37.1% to $0.108 on volume of 436,246,446 shares Ascent Solar Technologies Inc (ASTI) rose 114.8% to $0.282249 on volume of 221,176,942 shares OneMedNet Corp (ONMD) rose 134.7% to $1.15 o...

BMRN - BMRN Price Target Alert: $72.00. Issued by Robert W. Baird

2024-05-17 05:00:04 ET Jack Allen from Robert W. Baird issued a price target of $72.00 for BMRN on 2024-05-17 03:08:00. The adjusted price target was set to $72.00. At the time of the announcement, BMRN was trading at $76.97. The overall price target consensus is at $115...

Previous 10 Next 10